Phlebolymphology N°80

Phebolymphology N°80 – Editorial

Dear Readers, In this new issue, Christine Biron-Andréani from Montpellier presents an excellent review on the clinically very important issue of the thromboembolic risk in the postpartum period. Based on recommendations from the Royal College of Obstetricians and Gynaecologists, categories of very high, high, and intermediate risk are defined and prenatal and postnatal prophylaxis with low-molecular-weight heparin is suggested to be given for a period of time that should be adjusted to the risk group. An interesting overview on modern advancements in stent technologies including drug-eluting, biodegradable, and covered stents is presented by Nabil Chakfé and his group from Strasbourg,…

Full text

Venous thromboembolic risk in postpartum

Christine BIRON-ANDRÉANI, Hemophilia Center and Hemostasis Department, CHRU Montpellier, France ABSTRACT In 2010, venous thromboembolism (VTE) was the third leading cause of mortality among pregnant women in France accounting for 0.95 deaths per 100 000 deliveries; one-third of the deaths were considered to be avoidable. The highest risk period is postpartum and the increased risk persists for 6 weeks postpartum. During this period, the risk of pulmonary embolism is higher than the risk of deep vein thrombosis. Risk factors differ in the antepartum and postpartum period, but both clinical and genetic risk factors are important for predicting VTE during pregnancy…

Full text

Advances in stent technology for femoral artery lesions and use of stents forvenous pathology

Anne LEJAY1,2, Yannick GEORG1,2, Elvira TARTA GLIA1, Fabien THAVEAU1,2, Philippe NICOLINI3, Nabil CHAKFE1,2 1. Department of Vascular Surgery, University Hospital of Strasbourg and University of Strasbourg, Strasbourg, France. 2. European Research Group on Grafts used in Vascular Surgery (GEPROVAS), Strasbourg, France. 3. Clinique du Parc, Lyon, France. ABSTRACT Endovascular surgery with femoral superficial artery stent implantation was first conducted over 20 years ago. However, the first experiments with steel stents were relatively disappointing. A notable advance was the development of nitinol stents, which led to an initial improvement in clinical outcomes, but a relatively high rate of fractures. A better…

Full text

Can Micronized Purified Flavonoid Fraction* (MPFF) improve outcomes of lower extremity varicose veinendovenous treatment?First results from the DECISION study

Vadim Yu BOGACHEV,1 Olga V. GOLOVANOVA,1 Alexey N. KUZNETSOV,1 Anna O. SHEOKYAN,1 and the DECISION Investigators group.2 1. Department of Angiology and Vascular Surgery, Russian State Medical University, Moscow, Russian Federation 2. Belentsov S M (Yekaterinburg), Vakhitov M Sh (St.Petersburg), Krygyn S G (Samara), Serazhitdinov A Sh (Chelyabinsk), Sapelkyn S V (Moscow), Parikov M.A. (St.Petersburg), Kudykin M N (Nizhny Novgorod), Gusarev D.A. (Rostov-on-Don), Guzhkov O N (Yaroslavl), Krasavin D.S. (Nizhny Novgorod), Lutsenko M M (Moscow), Ryzhov A N (Chelyabinsk), Batakov S.S. (Yekaterinburg), Khitaryan A G (Rostov-on-Don), Kletskin A E (Nizhny Novgorod). ABSTRACT Aim: To evaluate whether the addition of Micronized…

Full text

Superficial vein thrombosis: more dangerous than anticipated

Denis L. CLEMENT University of Ghent, B-9000 Ghent, Belgium ABSTRACT Physicians were once taught that superficial venous thrombosis is a rather benign condition. However, more recent information suggests that in quite a number of cases this thrombosis may be complicated by pulmonary embolism. Diverse mechanisms play a role in its development, but it is most frequently linked to varicose veins. Diagnosis is clinical, but ultrasound visualization of the venous segment is essential for the initiation of adequate management. Compression and mobilisation are the cornerstones of treatment. For a short segment thrombosis, nonsteroidal anti-inflammatory drugs exert a proven favorable effect. For…

Full text

Critical role of the vasa venarum in the pathogenesis of chronic venous disease. Part I: malperfused venules as pathogenetic hot spots

This is the first of the 2 chapters that make up the “critical role of the vasa venarum in the pathogenesis of CVD.” These chapters will be published consecutively in Phlebolymphology. Stephan NEES1*, Dominik R. WEISS2*, Gerd JUCHEM3, Hugo PARTSCH4 1 Department of Physiology, University of Munich (LMU), 80336 Munich, Germany 2 Department of Transfusion Medicine and Hemostaseology, University of Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany 3 Department of Cardiac Surgery, University of Munich (LMU), 81377 Munich, Germany 4 Emeritus Professor of Dermatology, Medical University of Vienna, Austria ABSTRACT A new concept for the pathogenesis of venous disease is presented in…

Full text

Phlebolymphology N°80 (Vol 20 – N°4 – 2013)

EDITORIAL Editorial Hugo Partsch – (Vienna, Austria) – Phlebolymphology – 2013 ; 20 (4): 166 PHLEBOLOGY Venous thromboembolic risk in postpartum Christine BIRON-ANDRÉANI – (Montpellier, France) – Phlebolymphology – 2013 ; 20 (4): 167 Advances in stent technology for femoral artery lesions and use of stents for venous pathology Anne LEJAY, Yannick GEORG, Elvira TARTA GLIA, Fabien THAVEAU, Philippe NICOLINI, Nabil CHAKFE – (Strasbourg, France; Lyon, France) – Phlebolymphology – 2013 ; 20 (4): 174 Can Micronized Purified Flavonoid Fraction (MPFF) improve outcomes of lower extremity varicose vein endovenous treatment? First results from the DECISION study Vadim Yu BOGACHEV, Olga…

Full text